Ionis Pharmaceuticals, INC.

Biotechnology company.

Based in CA

🤖

AI Overview

With $200K in lobbying spend across 7 quarterly filings, Ionis Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.

$200K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2024	$40K
2025	$160K

Issues Lobbied

Health Issues

Lobbying Firms

Lmh Strategic Solutions

Lobbyists

Alanna Temme Sonia Goh

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

•Issues related to the implementation of H.R.5547/S.476 - Maintaining Investments in New Innovation Act and H.R.7384 - Creating Hope Reauthorization Act of 2024.

•Issues related to the implementation of H.R.5547/S.476 - Maintaining Investments in New Innovation Act and H.R.7384 - Creating Hope Reauthorization Act of 2024. Pediatric Review Reauthorization. H.R.5

•Issues related to the implementation of H.R.5547/S.476 - Maintaining Investments in New Innovation Act and H.R.7384 - Creating Hope Reauthorization Act of 2024. Pediatric Review Reauthorization. H.R.9

•Pediatric Review Reauthorization. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1672 - Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025.